Tandem Diabetes Care Inc (OQ:TNDM)

Business Focus: Medical Equipment, Supplies & Distribution

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for TNDM within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 16th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 13/20 Berger David B Direct Ownership Stock Option M - Exercise or conversion exempt under rule 16b-3 -16,000  
Feb 14/20 Feb 13/20 Berger David B Direct Ownership Common Stock S - Open market or private sale -16,000 $82.67
Feb 14/20 Feb 13/20 Berger David B Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 16,000 $2.59
Feb 12/20 Feb 11/20 Vosseller Leigh Direct Ownership Stock Option M - Exercise or conversion exempt under rule 16b-3 -3,626  
Feb 12/20 Feb 11/20 Vosseller Leigh Direct Ownership Common Stock S - Open market or private sale -3,626 $80.00
Feb 12/20 Feb 11/20 Vosseller Leigh Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 3,626 $2.59
Feb 12/20 Feb 10/20 Vosseller Leigh Direct Ownership Stock Option M - Exercise or conversion exempt under rule 16b-3 -6,374  
Feb 12/20 Feb 10/20 Vosseller Leigh Direct Ownership Common Stock S - Open market or private sale -6,374 $80.06
Feb 12/20 Feb 10/20 Vosseller Leigh Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 6,374 $2.59
Feb 4/20 Feb 3/20 Berger David B Direct Ownership Stock Option M - Exercise or conversion exempt under rule 16b-3 -2,000  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for TNDM within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 16th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 13/20 Berger David B Direct Ownership Stock Option M - Exercise or conversion exempt under rule 16b-3 -16,000  
Feb 14/20 Feb 13/20 Berger David B Direct Ownership Common Stock S - Open market or private sale -16,000 $82.67
Feb 14/20 Feb 13/20 Berger David B Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 16,000 $2.59
Feb 12/20 Feb 11/20 Vosseller Leigh Direct Ownership Stock Option M - Exercise or conversion exempt under rule 16b-3 -3,626  
Feb 12/20 Feb 10/20 Vosseller Leigh Direct Ownership Stock Option M - Exercise or conversion exempt under rule 16b-3 -6,374  
Feb 12/20 Feb 11/20 Vosseller Leigh Direct Ownership Common Stock S - Open market or private sale -3,626 $80.00
Feb 12/20 Feb 11/20 Vosseller Leigh Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 3,626 $2.59
Feb 12/20 Feb 10/20 Vosseller Leigh Direct Ownership Common Stock S - Open market or private sale -6,374 $80.06
Feb 12/20 Feb 10/20 Vosseller Leigh Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 6,374 $2.59
Feb 4/20 Feb 3/20 Berger David B Direct Ownership Stock Option M - Exercise or conversion exempt under rule 16b-3 -2,000  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $TNDM

Competitors

Competitors with Recent Insider Filings
DexCom (OQ:DXCM)
Medtronic PLC (N:MDT)
Haemonetics (N:HAE)